+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Effects of erythromycin on human gastrointestinal motility

Effects of erythromycin on human gastrointestinal motility

Acta Academiae Medicinae Shanghai 24(2): 97-99

Purpose: To evaluate the effects of erythromycin on human gastrointestinal motility. Methods: 14 Volunteers were given either intravenous (7 mg/kg) or oral (500 mg) erythromycin. The gastrointestinal motility was recorded and compared before and after the administration of the drug. Results: Gastric MMC was interrupted after i.v. erythromycin and replaced by irregular contraction pattern. The contracts of stomach were increased from 19 to 63 (P lt 0.01) and the amplitude was increased from 6.67 apprx 10 kPa to gt 13.33 kPa. In the oral erythromycin group the number of MMC increased from 6 to 15 and the duration was decreased (P lt 0.05). Different from the stomach the contract of small intestine was significantly decreased after the erythromycin administration. Conclusions: As erythromycin has different effects on stomach and small intestine it can be used for treatment of gastroparesis but not for pseudo obstruction of intestine.

(PDF 0-2 workdays service: $29.90)

Accession: 008566336

Download citation: RISBibTeXText

Related references

Effects of erythromycin on gastrointestinal tract motility. Journal of Antimicrobial ChemoTherapy 16 Suppl A: 175-179, 1985

Effects of GM-611, a novel erythromycin derivative, on gastrointestinal motility and gastric emptying in dogs. Japanese Journal of Pharmacology 64(SUPPL 1): 283P, 1994

Effects of erythromycin on the propulsive motility of upper gastrointestinal tract in rats. Gaginella, T. S. , Mozsik, G. , Rainsford, K. D. Biochemical Pharmacology As An Approach To Gastrointestinal Disorders: Basic Science To Clinical Perspectives (1996). 125-130, 1997

Effects of low dose erythromycin on gastrointestinal motility and symptoms in chronic intestinal pseudoobstruction. Gastroenterology 100(5 PART 2): A41, 1991

Effects of erythromycin on antroduodenal motility in children with chronic functional gastrointestinal symptoms. Gastroenterology 100(5 PART 2): A437, 1991

Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility. Journal of Pediatric Gastroenterology and Nutrition 24(4): 411-418, 1997

Effects of GM-611, a novel erythromycin derivative, on gastrointestinal motility and gastric emptying in conscious rhesus monkeys. Japanese Journal of Pharmacology 64(SUPPL 1): 283P, 1994

Effects of different doses of oral erythromycin on small bowel motility in functional gastrointestinal disease. Gastroenterology 104(4 SUPPL ): A505, 1993

Comparison of the side effects and gastrointestinal motility observed after administration of erythromycin and josamycin to dogs. Journal of Antimicrobial ChemoTherapy 18(6): 747-756, 1986

Oral erythromycin accelerates impaired human interdigestive gastrointestinal motility after endoscopic mucosal resection. Gastroenterology 110(4 SUPPL ): A692, 1996

Effects of oral erythromycin on upper gastrointestinal motility in patients with non-insulin-dependent diabetes mellitus. Nuclear Medicine Communications 16(9): 790-793, 1995

Erythromycin and gastrointestinal motility. Lancet 2(8566): 1036-1036, 1987

Erythromycin in gastrointestinal motility disturbances. Annals of PharmacoTherapy 26(9): 1095-1097, 1992

Erythromycin eye ointment: effect on gastrointestinal motility. American Journal of Gastroenterology 95(3): 826-826, 2000

Effect of erythromycin on gastrointestinal motility after Billroth II resection. Journal of Nuclear Medicine 42(5 Supplement): 131P, 2001